Redwood AI Launches Chemical Risk Assessment Initiative, Appoints Stanford Chemist as Scientific Advisor
June 22nd, 2026 1:05 PM
By: Newsworthy Staff
Redwood AI Corp. announced the development of a Chemical Risk Assessment Module for its Reactosphere platform and the appointment of Stanford University chemistry professor Dr. Noah Burns as a scientific advisor, aiming to enhance chemical safety and responsible AI-enabled chemistry research.

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) has launched development of a Chemical Risk Assessment Module within its Reactosphere platform and appointed Stanford University chemistry professor Dr. Noah Burns as a scientific advisor. The initiative is designed to strengthen chemical safety, hazardous material screening and responsible AI-enabled chemistry research through collaboration with academic and industry participants.
The company said the new module will support the development of chemical risk datasets, safety assessment tools and user feedback mechanisms that can enhance both its Reactosphere and Q-SAFE platforms. Redwood expects the effort to support applications across pharmaceutical development, industrial chemistry, security and public safety, while helping users identify potential hazards, prioritize compounds and incorporate risk considerations earlier in the research process. Dr. Burns will also provide strategic guidance on the company’s R&D roadmap and the advancement of AI-powered tools for synthetic chemistry.
The Chemical Risk Assessment Module represents a significant step in integrating safety considerations into AI-driven chemistry. By leveraging Dr. Burns' expertise in synthetic chemistry, Redwood aims to develop tools that can predict and mitigate risks associated with chemical reactions and compounds. This is particularly important for industries where hazardous materials are commonly used, as early identification of potential dangers can prevent accidents and improve regulatory compliance.
Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.
The announcement underscores the growing trend of integrating AI into chemical research to enhance safety and efficiency. As AI tools become more prevalent in laboratories, the ability to assess chemical risks automatically could become a standard feature. This initiative may set a precedent for other companies in the sector, encouraging further investment in AI safety modules.
For more information about Redwood AI Corp., visit the company’s newsroom at https://ibn.fm/RDWCF.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
